Eris Lifesciences Share Price Target for 2023 to 2050 is based on the company’s growth prospects:— Eris Lifesciences is a well-known name in the Indian pharmaceutical industry, renowned for its quality medicines and customer-centric approach. The company has established itself as a leading player in the market, with a diverse portfolio of products and a strong distribution network.
In this blog post, we will take a closer look at Eris Lifesciences share price target with a comprehensive overview of the company’s stock price. So, whether you are a long-time shareholder or are considering investing in Eris Lifesciences for the first time, we will also provide an analysis of Eris Lifesciences performance and the outlook for its future growth.
it’s Your Favorite…
Eris Lifesciences Overview
Eris Lifesciences Limited is a pharmaceutical company based in Ahmedabad, India. The company is known for its focus on developing and marketing high-quality, affordable medicines in India and other emerging markets.
Industry: Eris Lifesciences Limited operates in the pharmaceutical industry, which is a highly regulated and competitive sector. The industry is focused on developing, manufacturing, and marketing drugs and other pharmaceutical products for the treatment of various medical conditions.
Founded: Eris Lifesciences Limited was founded in 2007 by Amit Bakshi, a seasoned pharmaceutical executive with more than 25 years of experience in the industry. The company started operations as a small startup with a focus on the chronic and lifestyle segments of the Indian pharmaceutical market.
Founder: Amit Bakshi is the founder of Eris Lifesciences Limited. He is a graduate of the National Institute of Pharmaceutical Education and Research (NIPER) and has worked for several leading pharmaceutical companies in India and abroad before starting Eris.
Headquarters: Eris Lifesciences Limited has its headquarters in Ahmedabad, Gujarat, India. The company’s state-of-the-art manufacturing facilities are also located in Ahmedabad, and it has a strong presence in other cities across India.
Area served: Eris Lifesciences Limited primarily serves the Indian market, which is one of the fastest-growing pharmaceutical markets in the world. The company also has a presence in other emerging markets, including Nepal, Sri Lanka, and Myanmar.
Products: Eris Lifesciences Limited offers a wide range of pharmaceutical products, including tablets, capsules, injectables, and syrups. The company’s product portfolio includes drugs for the treatment of chronic and lifestyle diseases such as hypertension, diabetes, and depression, as well as antibiotics and other medicines for acute conditions.
Services: Eris Lifesciences Limited offers a range of services to its customers, including product registration, medical information, and pharmacovigilance. The company also provides training and support to healthcare professionals to help them better understand the drugs and treatments it offers.
Stock Exchange: Eris Lifesciences Limited is listed on the National Stock Exchange (NSE) and the Bombay Stock Exchange (BSE) in India. Its shares are traded under the ticker symbol ERIS on both exchanges.
Website URL: Eris Lifesciences Limited’s website URL is www.erislifesciences.com. The website provides information about the company’s products, services, and operations, as well as investor relations and corporate governance information.
One way to check the Eris Lifesciences share price target/forecast is to look at the research reports and analysis provided by financial institutions and brokerage firms. These firms often provide detailed reports on the company’s financials and future outlook, along with recommendations and target prices.
|17 Mar 2023
|18 JAN 2023
|18 JAN 2023
|25 OCT 2022
|08 AUG 2022
|16 MAY 2022
|05 MAY 2022
|05 MAY 2022
|29 JAN 2022
|BOB Capital Markets Ltd.
|27 DEC 2021
|07 DEC 2021
|BOB Capital Markets Ltd.
|06 DEC 2021
As an investor, you may be wondering what the future holds for Eris Lifesciences and its share price. we’ll take a look at the current state of Eris Lifesciences and try to predict what is Eris Lifesciences share price target for 2023, 2025, 2027, 2030, 2035, 2040, and 2050 is based on the company’s growth prospects:—
Based on current market trends, Eris Lifesciences is expected to continue its growth trajectory in 2023. The minimum target for the share price is INR 620, while the maximum target is INR 700.
Eris Lifesciences is expected to grow at a steady pace in 2024. The minimum target for the share price is INR 700, while the maximum target is INR 800.
In 2025, Eris Lifesciences is expected to continue its growth story. The minimum target for the share price is INR 800, while the maximum target is INR 900.
Eris Lifesciences is expected to grow at a faster pace in 2026. The minimum target for the share price is INR 900, while the maximum target is INR 1000.
Eris Lifesciences is expected to continue its strong performance in 2027. The minimum target for the share price is INR 1000, while the maximum target is INR 1200.
In the long term, Eris Lifesciences is expected to continue its growth trajectory. By 2030, the minimum target for the share price is INR 1500, while the maximum target is INR 2000.
In 2040, Eris Lifesciences is expected to be a mature company, with a well-established market presence. The minimum target for the share price is INR 4000, while the maximum target is INR 5000.
By 2050, Eris Lifesciences is expected to have grown into a major pharmaceutical company, with a strong global presence. The minimum target for the share price is INR 10,000, while the maximum target is INR 15,000.
— We’ll take a look at the current state of Eris Lifesciences and try to predict share price targets for each year from 2023 to 2050.
— As of 19 March 2023, the current share price of Eris Lifesciences Limited is INR 559.60Rs. Check out the latest price of Eris Lifesciences.
— To determine the Eris Lifesciences share price target today or tomorrow We will also provide an analysis of Eris Lifesciences performance and the outlook for its future growth.
— The last research report published by Motilal Oswal was on 17 Mar 2023, In this case, Motilal Oswal has set a target price of 710 Rs. for Eris Lifesciences stock.
That these share price targets for “Eris Lifesciences” are only provided for informational purposes only. It does not constitute a recommendation to buy, sell or hold Eris Lifesciences stock. Investors should conduct their own research and analysis and consult with financial experts before making any investment decisions.